Loading live market data…

Travere Therapeutics, Inc.

NASDAQ:TVTX

$57.06 USD

$0.77 (1.37%)

Volume
890.17K
Average Volume
2.52M
Market Capitalization
$5.31B
P/E Ratio
-116.45
Dividend Yield
0.00%
Price Target
$65.00
Year High
$60.10
Year Low
$15.03
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.13
Analyst Rating

Strong Sell

1 Rating Score

UPSIDE/DOWNSIDE

-12.2% DOWNSIDE

$65.00 Price Target

UPSIDE/DOWNSIDE HIGH

-14.8% DOWNSIDE

$67.00 Price Target High

UPSIDE/DOWNSIDE LOW

16.4% UPSIDE

$49.00 Price Target Low

INSIDER TRADING

Shares

$- Last Quarter

TVTX Upgrades Downgrades Consensus

Overall Consensus: Buy  |  Total Analysts: 18

Strong Buy Buy Hold Sell Strong Sell
0 15 3 0 0
Analyst Company Analyst Name Price Target Price When Posted Date Upside/Downside
Guggenheim Vamil Divan $65 $59.4 2026-06-25 07:38 AM 9.4%
H.C. Wainwright Joseph Pantginis $67 $42.96 2026-06-02 11:38 AM 56.0%
Guggenheim Vamil Divan $49 $28.392 2026-01-14 06:48 AM 72.6%
Jefferies Maury Raycroft $35 $27.31 2025-09-10 10:48 AM 28.2%
Evercore ISI Liisa Bayko $33 $17.5 2024-10-31 04:21 PM 88.6%
Wells Fargo Mohit Bansal $27 $17.87 2024-10-21 01:38 AM 51.1%
Evercore ISI Liisa Bayko $30 $18.07 2024-10-10 05:24 AM 66.0%
Bank of America Securities Jason Zemansky $20 $15.21 2024-10-09 02:57 AM 31.5%